Bayer CEO Highlights India's Growing Role in Global Strategy

Bayer Targets India as One of Its Top Markets by 2030, Expands Innovation and Investment Push​

Bayer CEO Bill Anderson Outlines Strategic Growth Plans for India​

Bayer AG Chief Executive Officer Bill Anderson has outlined an ambitious plan to elevate India into one of the company’s top global markets by 2030. The German life sciences company is supporting this strategy through investments across its three key divisions: crop science, pharmaceuticals, and consumer health.

Speaking in Bengaluru during the inauguration of Bayer’s new innovation hub, Anderson said the company now views India as far more than a back office for global operations. He emphasized that the work produced at the facility contributes directly to Bayer’s worldwide activities.

According to Anderson, the Bengaluru center is engaged in imaging research and development, pharmaceutical research, and crop science genetics, with its output supporting Bayer’s global workforce of around 88,000 employees.

Bengaluru Innovation Hub to Support Global Research and Development​

Anderson highlighted that the Bengaluru hub plays a significant role in Bayer’s global innovation network. The work conducted at the facility contributes to multiple international research programs and supports teams across the company’s global operations.

He noted that India is transitioning from being primarily an execution center to becoming a source of intellectual and research output. The shift is reflected in the growing number of global research and development mandates now being handled from the Bengaluru center.

Long-Term Commitment to India​

Bayer has maintained a long-standing presence in India for more than 130 years and currently employs around 13,000 people in the country. The company operates several major facilities, including a data science and analytics center in Hyderabad, a global capability center in Mumbai, a global business center, and the expanded digital and research hub in Bengaluru.

Crop science remains Bayer’s largest business segment in India in terms of revenue.

While India is not currently among Bayer’s top markets, Anderson said the company intends to change that within the next decade, with growth opportunities expected across all three divisions.

Agricultural Initiatives Expanding Across Rural India​

During his visit to India, Anderson also reviewed Bayer’s agricultural initiatives, including its Better Life Farming program operating near Varanasi. The initiative currently runs at about 1,500 locations across the country.

These centers provide smallholder farmers with seeds, crop protection products, access to credit, agronomic advice, and drone-based pesticide spraying services.

Anderson described meeting young women entrepreneurs running village stores through the program, noting that they have become key contributors within their communities.

Consumer Health and Pharmaceutical Expansion​

Bayer is also expanding its consumer health and pharmaceutical businesses in India.

In consumer health, the company is focusing on increasing distribution to reach lower-income populations. The segment includes products such as nutrition supplements and headache relief medicines under brands like Supradyn and Saridon.

In pharmaceuticals, Bayer is strengthening its cardiovascular therapy portfolio and has introduced new clinical data related to heart failure treatments.

Organizational Changes to Enable Local Decision Making​

Bayer is also implementing structural changes aimed at decentralizing decision making across its global operations.

Over the past two and a half years, the company has introduced a model called Dynamic Shared Ownership. As part of this initiative, Bayer eliminated roughly two-thirds of its management positions worldwide and expanded the average management span from six direct reports to about sixteen.

According to Anderson, the model is designed to move decision making closer to operational teams. As Bayer continues to expand its talent base in India, the company expects greater decision-making authority to be placed within the country’s teams.